The prevalence of anemia in chronic heart failure
- 30 November 2002
- journal article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 86 (1), 115-121
- https://doi.org/10.1016/s0167-5273(02)00273-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled studyJournal of the American College of Cardiology, 2001
- The pathological consequences of anaemiaClinical and Laboratory Haematology, 2001
- IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000American Journal of Kidney Diseases, 2001
- Pathophysiology of anaemia: focus on the heart and blood vesselsNephrology Dialysis Transplantation, 2000
- Management of early renal anaemia: diagnostic work‐up, iron therapy, epoetin therapyNephrology Dialysis Transplantation, 2000
- The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizationsJournal of the American College of Cardiology, 2000
- The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity - the experience of the Lombardy Dialysis RegistryNephrology Dialysis Transplantation, 1998
- Renal Anaemia Treatment with Recombinant Human Erythropoietin Increases Cardiac Output in Patients with Ischaemic Heart DiseaseScandinavian Journal of Urology and Nephrology, 1996
- Therapy with Recombinant Human Erythropoietin Reduces Cardiac Size and Improves Heart Function in Chronic Hemodialysis PatientsAmerican Journal of Nephrology, 1991
- Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietinThe Lancet, 1990